Valerius Biopharma AG develop biosimilar drugs for therapeutic indications with high medical need. The product pipeline consists of four orphan and non-orphan biosimilar drugs that will be developed according to highest regulatory standards to enable global access for patients at affordable prices.


Stänzlergasse 4, 4051 Basel, Schweiz

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business